AN INSIGHT ON THE ANTIGENIC PREPARATION STRATEGIES INVOLVED IN THE PRODUCTION OF POLYCLONAL ANTIBODIES AGAINST OLIGODENDROGLIOMAS (CEREBRAL TUMORS).

Kapoor R.A.1, Ladak S.S.2, Balaji S. Rao3, Gomase V.S.4
1Padmashree Dr. D.Y. Patil University, Navi Mumbai, 400614, India
2Padmashree Dr. D.Y. Patil University, Navi Mumbai, 400614, India
3NTHRYS, Hyderabad
4School of Technology, S.R.T.M. University, Sub-Centre, Latur, 413512, India

Received : -     Accepted : -     Published : 15-06-2010
Volume : 1     Issue : 1       Pages : 11 - 17
J Clin Res Lett 1.1 (2010):11-17
DOI : http://dx.doi.org/10.9735/0976-7061.1.1.11-17

Conflict of Interest : None declared

Cite - MLA : Kapoor R.A., et al "AN INSIGHT ON THE ANTIGENIC PREPARATION STRATEGIES INVOLVED IN THE PRODUCTION OF POLYCLONAL ANTIBODIES AGAINST OLIGODENDROGLIOMAS (CEREBRAL TUMORS).." Journal of Clinical Research Letters 1.1 (2010):11-17. http://dx.doi.org/10.9735/0976-7061.1.1.11-17

Cite - APA : Kapoor R.A., Ladak S.S., Balaji S. Rao, Gomase V.S. (2010). AN INSIGHT ON THE ANTIGENIC PREPARATION STRATEGIES INVOLVED IN THE PRODUCTION OF POLYCLONAL ANTIBODIES AGAINST OLIGODENDROGLIOMAS (CEREBRAL TUMORS).. Journal of Clinical Research Letters, 1 (1), 11-17. http://dx.doi.org/10.9735/0976-7061.1.1.11-17

Cite - Chicago : Kapoor R.A., Ladak S.S., Balaji S. Rao, and Gomase V.S. "AN INSIGHT ON THE ANTIGENIC PREPARATION STRATEGIES INVOLVED IN THE PRODUCTION OF POLYCLONAL ANTIBODIES AGAINST OLIGODENDROGLIOMAS (CEREBRAL TUMORS).." Journal of Clinical Research Letters 1, no. 1 (2010):11-17. http://dx.doi.org/10.9735/0976-7061.1.1.11-17

Copyright : © 2010, Kapoor R.A., et al, Published by Bioinfo Publications. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution and reproduction in any medium, provided the original author and source are credited.

Abstract

Various strategies have been used to identify and characterize the antigens associated with human brain tumors. These approaches have included the raising of polyclonal and antibodies against tumor antigens and, more recently, efforts toward the direct biochemical identification of such proteins. This article summarizes the progress made in this area, suggests reasons for the broad antigenic cross-reactivity and heterogeneity revealed by these studies, and proposes additional methods such as radial and double immunodiffusion and ELISA for deciphering the complex antigenic composition of human brain tumors.

References

[1] Inskip PD, Linet MS, Heineman EF. Etiology of brain tumors in adults. Epidemiol.Rev 1995;17(2): 382–414.  
» CrossRef   » Google Scholar   » PubMed   » DOAJ   » CAS   » Scopus  

[2] Malmer B, Henriksson R, Gronberg H. Different aetiology of familial low-grade and high-grade glioma? A nationwide cohort study of familial glioma. Neuroepidemiology, 2002; 21(6):279– 286.  
» CrossRef   » Google Scholar   » PubMed   » DOAJ   » CAS   » Scopus  

[3] Melean G, Sestini R, Ammannati F, Papi L. Genetic insights into familial tumors of the nervous system. Am J Med Genet C Semin Med Genet, 2004 Aug 15; 129(1):74–84  
» CrossRef   » Google Scholar   » PubMed   » DOAJ   » CAS   » Scopus  

[4] GLOBOCAN. Worldwide Incidence and Mortality of Cancer, 2002 [computer program]. Version. Lyon, France: IARC.  
» CrossRef   » Google Scholar   » PubMed   » DOAJ   » CAS   » Scopus  

[5] Louis D, Ohgaki H, Wiestler O, 'et al. .The 2007 WHO Classification of Tumours of the Central Nervous System . Acta Neuropathologica, 2007. 114 (2): 97–109.  
» CrossRef   » Google Scholar   » PubMed   » DOAJ   » CAS   » Scopus  

[6] Sherise Ferguson, M.A., and Maciej S. Lesniak . Percival Bailey and the Classification of Brain Tumors. American Association of Neurological Surgeons, 2005; 18(4).  
» CrossRef   » Google Scholar   » PubMed   » DOAJ   » CAS   » Scopus  

[7] Celli P, Nofrone I, Palma L, et al. Cerebral oligodendroglioma: prognostic factors and life history. Neurosurgery, 1994;35(6):1018-34.  
» CrossRef   » Google Scholar   » PubMed   » DOAJ   » CAS   » Scopus  

[8] Nutt CL, Costello JF, Bambrick LL et al. O6 methylguanine-DNA methyltransferase in tumors and cells of the oligodendrocyte lineage. Can J Neurol Sci ,1995;22:111–115.  
» CrossRef   » Google Scholar   » PubMed   » DOAJ   » CAS   » Scopus  

[9] Kros JM, van der Weiden M, Zheng PP et al. Intratumoral distribution of 1p loss in oligodendroglial tumors. J Neuropathol Exp Neurol, 2007;66:1118–1123.  
» CrossRef   » Google Scholar   » PubMed   » DOAJ   » CAS   » Scopus  

[10] Lavon I, Zrihan D, Zelikovitch B et al. Longitudinal assessment of genetic and epigenetic markers in oligodendrogliomas. Clin Cancer Res, 2007;13:1429–1437.  
» CrossRef   » Google Scholar   » PubMed   » DOAJ   » CAS   » Scopus  

[11] Jones, P. A., and Baylin, S. B. The fundamental role of epigenetic events in cancer. Nat. Rev Genet.,2002; 3: 415–428.  
» CrossRef   » Google Scholar   » PubMed   » DOAJ   » CAS   » Scopus  

[12] Neuhoff V., Stamm R., Eibl H., Electrophoresis, modified by A. Posch, 1985; 6:427-448.  
» CrossRef   » Google Scholar   » PubMed   » DOAJ   » CAS   » Scopus  

[13] Graham S. Bailey, Ouchterlony Double Immunodiffusion. Springer link, 1996; 749-752.  
» CrossRef   » Google Scholar   » PubMed   » DOAJ   » CAS   » Scopus  

[14] Engvall E, Perlman P . "Enzyme-linked immunosorbent assay (ELISA). Quantitative assay of immunoglobulin G". Immunochemistry, 1971; 8 (9): 871–4.  
» CrossRef   » Google Scholar   » PubMed   » DOAJ   » CAS   » Scopus